Physician profile
David Harris Freeman
NPI 1902929268
$1,166.65
in general payments reported to CMS, 2019-2025
12 companies · $191 in 2025
The $191 reported for 2025 was more than what a typical Orthodontics and Dentofacial Orthopedics provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $141 · 2020: $102 · 2021: $168 · 2022: $67.24 · 2023: $208 · 2024: $290 · 2025: $191.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $330 · Honoraria: $208 · Consulting Fee: $150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $329.99 |
| Honoraria | $208.38 |
| Consulting Fee | $150.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Align Technology, INC. | $442.52 | 2020-2024 | Invisalign |
| Benco Dental Supply Co. | $246.21 | 2022-2025 | |
| Biohorizons Implant Systems INC. | $177.19 | 2019-2022 | |
| Lightforce Orthodontics, INC. | $62.75 | 2024 | |
| USA Angelalign Technology Corp | $58.16 | 2025 | |
| Owens & Minor | $57.15 | 2023 | |
| American Orthodontics Corporation | $42.27 | 2023-2025 | Radiance, Empower-Ceramic, LP and Ifit Tubes |
| Carestream Dental, LLC | $23.81 | 2021 | |
| Envista Holdings Corporation | $18.97 | 2025 | Spark |
| Nobel Biocare USA | $13.64 | 2023 | Nobelactive |
| Dentsply Sirona INC | $12.03 | 2019 | |
| Gc America INC. | $11.95 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Freeman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.